News
- Author:
- Andrew D. Bowser
Publish date: December 23, 2022
With current therapies, patients who achieve 24 months of event-free survival live almost as long as the general population.
News
- Author:
- Andrew D. Bowser
Publish date: December 16, 2022
The second-generation Bruton’s tyrosine kinase inhibitor zanubrutinib outperformed ibrutinib in a phase 3 study.
News
- Author:
- Andrew D. Bowser
Publish date: December 5, 2022
The findings apparently contradict the survival benefit seen in clinical trial data, authors said, but are consistent with other recent observation...
News
- Author:
- Andrew D. Bowser
Publish date: November 18, 2022
In patients with mantle cell lymphoma, long-term complications appeared to be caused by the disease itself, not by intensive therapy.
News
- Author:
- Andrew D. Bowser
Publish date: November 8, 2022
In a phase 3 trial of mantle cell lymphoma outcomes, repeated evaluations of minimal residual disease over time improved prognostic power.
News
- Author:
- Andrew D. Bowser
Publish date: December 16, 2021
The second COVID-19 wave brought zero deaths and fewer complicated hospitalizations at the largest U.S. adult sickle cell disease center, but care ...
News
- Author:
- Andrew D. Bowser
Publish date: December 14, 2021
New and emerging therapeutic developments hold the promise of extending survival for select patients.
<...
News
- Author:
- Andrew D. Bowser
Publish date: November 10, 2021
Genomic testing increases confidence and consensus, but can’t be used in a vacuum, speaker says.
News
- Author:
- Andrew D. Bowser
Publish date: November 3, 2021
The latest bronchoscopic interventions under investigation could be a “breath of fresh air” for patients with COP...
News
- Author:
- Andrew D. Bowser
Publish date: October 20, 2021
Investigations of concerning head lesions led to a suspicious chest mass, prompting an eventual correct diagnosis...
News
- Author:
- Andrew D. Bowser
Publish date: October 19, 2021
Greater recognition and more education is needed, according to an investigator who conducted a study of spirometry tests at a VA medical center.
News
- Author:
- Andrew D. Bowser
Publish date: October 18, 2021
Add-on treatment yielded significant improvements over 52 weeks in children with the type 2 phenotype, the most c...
News
- Author:
- Andrew D. Bowser
Publish date: October 13, 2021
Attempts to reintroduce egg into the child’s diet can start at the age of 12 months or 6 months from the last reaction.
News
- Author:
- Andrew D. Bowser
Publish date: September 28, 2021
In the mRNA COVID-19 vaccines, PEG serves to stabilize the lipid nanoparticles that help Read More
News
- Author:
- Andrew D. Bowser
Publish date: September 21, 2021
In an observational registry-based study, dropping the 110-bpm heart rate threshold improved sensitivity for low-risk PE, while increasing it impro...
